Smith R E, Palmer R M, Bucknall C A, Moncada S
Department of Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.
Cardiovasc Res. 1992 May;26(5):508-12. doi: 10.1093/cvr/26.5.508.
The aim was to study the effects on coronary vascular tone of three inhibitors of nitric oxide (NO) synthesis.
Studies were performed on isolated perfused hearts of 74 male New Zealand White rabbits fed normal laboratory diet. Resting coronary perfusion pressure was increased to 40-60 mm Hg with the thromboxane mimetic 9,11-dideoxy-9 alpha,11 alpha-methanoepoxy prostaglandin F2 alpha (U46619). The effects of NG-monomethyl-L-arginine (L-NMMA), N-iminoethyl-L-ornithine (L-NIO), and NG-nitro-L-arginine methyl ester (L-NAME) (0.3-300 microM) on resting coronary perfusion pressure were determined. The effects of these compounds, at concentrations that increased the resting perfusion pressure to a similar extent, on the fall in perfusion pressure induced by acetylcholine (0.1 microM) and glyceryl trinitrate (1 microM) were also investigated. In these studies the resting perfusion pressure was maintained at 40-60 mm Hg by reducing the concentration of U46619.
L-NMMA, L-NIO, and L-NAME induced concentration dependent increases in resting coronary perfusion pressure (n = 3-9, p < 0.05). L-NAME had the greatest potency and efficacy, increasing the resting pressure by 48.0(SEM 9.6) mm Hg at 30 microM. L-NIO and L-NMMA increased perfusion pressure by 27.3(3.0) and 19.5(5.8) mm Hg respectively at the maximum concentration studied (300 microM). However, at concentrations that were equieffective on resting perfusion pressure (15 mm Hg increase), L-NMMA (100 microM), but not L-NIO (25 microM) or L-NAME (4 microM), significantly inhibited the fall in pressure induced by acetylcholine by 57.2(5.0)%, n = 6, p < 0.05. This effect of L-NMMA++ was attributed to a shorter duration of fall and was reversed by L-arginine (300 microM). L-NMMA (100 microM) and L-NIO (25 microM) potentiated the effect of glyceryl trinitrate by increasing the peak fall in perfusion pressure by 75.6(11.0)% and 68.8(24.1)% respectively (n = 6 for each, p < 0.05).
The differential effects of the three inhibitors on resting coronary perfusion pressure and the acetylcholine induced fall in coronary perfusion pressure suggest that basal and stimulated NO synthesis may be differentially regulated. Reduction in the synthesis of endogenous NO by these compounds potentiates the glyceryl trinitrate induced fall in perfusion pressure, which may have important clinical implications.
研究三种一氧化氮(NO)合成抑制剂对冠状动脉血管张力的影响。
对74只食用普通实验室饲料的雄性新西兰白兔的离体灌注心脏进行研究。使用血栓素类似物9,11 - 二脱氧 - 9α,11α - 甲环氧前列腺素F2α(U46619)将静息冠状动脉灌注压提高到40 - 60 mmHg。测定NG - 单甲基 - L - 精氨酸(L - NMMA)、N - 亚氨基乙基 - L - 鸟氨酸(L - NIO)和NG - 硝基 - L - 精氨酸甲酯(L - NAME)(0.3 - 300μM)对静息冠状动脉灌注压的影响。还研究了这些化合物在使静息灌注压升高程度相似的浓度下,对乙酰胆碱(0.1μM)和硝酸甘油(1μM)诱导的灌注压下降的影响。在这些研究中,通过降低U46619的浓度将静息灌注压维持在40 - 60 mmHg。
L - NMMA、L - NIO和L - NAME引起静息冠状动脉灌注压呈浓度依赖性升高(n = 3 - 9,p < 0.05)。L - NAME的效力和效能最大,在30μM时使静息压力升高48.0(标准误9.6)mmHg。在研究的最大浓度(300μM)下,L - NIO和L - NMMA分别使灌注压升高27.3(3.0)和19.5(5.8)mmHg。然而,在对静息灌注压产生等效作用的浓度(升高15 mmHg)下,L - NMMA(100μM),而非L - NIO(25μM)或L - NAME(4μM),显著抑制乙酰胆碱诱导的压力下降,抑制率为57.2(5.0)%,n = 6,p < 0.05。L - NMMA的这种作用归因于下降持续时间较短,且可被L - 精氨酸(3μM)逆转。L - NMMA(100μM)和L - NIO(2μM)通过分别使灌注压的峰值下降增加75.6(11.0)%和68.8(24.1)%来增强硝酸甘油的作用(每组n = 6,p < 0.05)。
三种抑制剂对静息冠状动脉灌注压和乙酰胆碱诱导的冠状动脉灌注压下降的不同作用表明,基础和刺激状态下的NO合成可能受到不同调节。这些化合物使内源性NO合成减少,增强了硝酸甘油诱导的灌注压下降,这可能具有重要的临床意义。